Effective immediate allocation and streamlined delivery to the recipient states and UTs and institutions is an ongoing exercise, said the Union Health Ministry.
May 25, 2021
Remdesivir and Faviflu have been approved by the Central Drug Standard Control Organisation (CDSCO) and were notified for use for Covid patients by the Central government in June-July, 2020. The said notification was made by the Central government u/s 2A of the Epidemic Decease Act, 1897.
May 22, 2021
New Delhi: India cumulatively has so far received three lakh Remdesivir vials, 6,608 oxygen concentrators, 3,856 oxygen cylinders…
May 10, 2021
The oral version is set to ease capacity constraints the injectable formulation faces and ensures timely availability for treating Covid patients.
April 20, 2021
NITI Aayog member (Health) V K Paul said that remdesivir is not to be used in home settings and not to be procured from chemist shops.
April 20, 2021
This dramatic clinical response was accompanied by a progressive decrease in levels of C-reactive protein (CRP), a substance produced by the liver in response to inflammation.
December 15, 2020
A total of 1,033 patients participated in the trail, with 515 assigned to combination treatment, and 518 to control group.
December 13, 2020
Less than a month ago, the Food and Drug Administration said hospitals could use remdesivir, a drug manufactured…
November 21, 2020
‘JUBI-R’ will require to be administered intravenously in a hospital setting under the supervision of a medical practitioner.
August 4, 2020
The members asked the government to check black marketing of life saving drugs such as Remdesivir and other such drugs.
July 16, 2020
The mortality rate for patients treated with remdesivir in the analysis was 7.6 per cent at Day 14 compared with 12.5 per cent among patients not taking remdesivir.
July 11, 2020
The mortality rate for Covid-19 in ICUs varies from country to country and hospital to hospital, so the number of lives saved from increased ICU capacity would also vary, the study said.
July 8, 2020
The Central Drugs Standard Control Organisation has given approval for the manufacturing and marketing of Remdesivir to Cipla, Hetro and Mylan.
July 8, 2020
The US Food and Drug Administration on May 1 issued an emergency use authorisation for remdesivir for the treatment of suspected or laboratory-confirmed Covid-19 in adults and children hospitalised with severe disease.
June 9, 2020
India’s Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead…
May 12, 2020
Remdesivir is being studied in multiple ongoing international clinical trials, and the safety and efficacy of remdesivir for the treatment of Covid-19 are not yet established.
May 6, 2020
Meanwhile, the confirmed Covid-19 cases in the country crossed 42,000 mark with over 1,300 deaths.
May 4, 2020